Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Deals

DSM Buys Device Component Maker Kensey Nash To Bolster Biomedical Materials Offerings

This article was originally published in The Gray Sheet

Executive Summary

Deal worth $360 million will help establish DSM as a major device industry materials supplier, strengthening offerings of bio-passive, bio-active and bio-interactive materials technologies.

You may also be interested in...



News In Brief

Kensey Nash and St. Jude Medical settle royalties spat. More news briefs.

News In Brief

Kensey Nash picks up Norian

Bridge Too Far? BMS Launch Plan For Sotyktu Pressured By Prospect Of Medicare Price Controls

With price controls in Medicare looming nine years after approval, launch strategies such as ‘bridge’ programs that build initial volume with free drug may have to be adjusted.

Table

View full table

Topics

Related Companies

Tags:
Medical Device Deals
Latest Headlines

News We’re Watching – LivaNova And Medtronic Recalls; Approvals For Abbott And Guardant; Pediatric Device Grants

Legal Expert Weighs In On New US Mandate To Diversify Clinical Trials

Global Medtech Guidance Tracker: January 2023

UK Medtech Strategy Promises To Use Innovation Effectively And Build Resilience

See All
UsernamePublicRestriction

Register

MT031195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By